UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by AIA Group Ltd

AIA Group Ltd reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.3% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 21,381 shares of the healthcare conglomerate’s stock after selling 1,436 shares during the period. AIA Group Ltd’s holdings in UnitedHealth Group were worth $11,256,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the company. Guardian Investment Management purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth about $1,911,000. Ninety One SA PTY Ltd boosted its stake in shares of UnitedHealth Group by 16.1% during the 4th quarter. Ninety One SA PTY Ltd now owns 23,199 shares of the healthcare conglomerate’s stock worth $12,214,000 after acquiring an additional 3,217 shares in the last quarter. Oliver Lagore Vanvalin Investment Group boosted its stake in shares of UnitedHealth Group by 12.6% during the 4th quarter. Oliver Lagore Vanvalin Investment Group now owns 214 shares of the healthcare conglomerate’s stock worth $113,000 after acquiring an additional 24 shares in the last quarter. NBW Capital LLC boosted its stake in shares of UnitedHealth Group by 3.1% during the 4th quarter. NBW Capital LLC now owns 10,858 shares of the healthcare conglomerate’s stock worth $5,716,000 after acquiring an additional 328 shares in the last quarter. Finally, Investors Asset Management of Georgia Inc. GA ADV lifted its stake in UnitedHealth Group by 7.1% in the 4th quarter. Investors Asset Management of Georgia Inc. GA ADV now owns 1,511 shares of the healthcare conglomerate’s stock valued at $790,000 after buying an additional 100 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Up 3.6 %

Shares of NYSE:UNH traded up $17.48 during trading on Thursday, hitting $496.47. The company’s stock had a trading volume of 6,545,578 shares, compared to its average volume of 4,492,220. The business has a 50 day moving average price of $489.51 and a two-hundred day moving average price of $515.38. The company has a market capitalization of $457.71 billion, a PE ratio of 30.38, a P/E/G ratio of 1.28 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.26 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.75 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.51%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Analyst Ratings Changes

A number of research analysts recently weighed in on UNH shares. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Truist Financial reissued a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday. Morgan Stanley cut their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Oppenheimer restated an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday. Three analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $569.68.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.